Roche Diagnostics
Search Contact Legal Statement
Index Sitemap link to Roche

 


AMPLICOR Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Test (CE-IVD & FDA-IVD)

The AMPLICOR CT/NG Test

The AMPLICOR CT/NG Test is a qualitative in vitro test for the detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae in urine from males and females**, in endocervical swab specimens, and in male urethral swab specimens***. The test utilizes the polymerase chain reaction (PCR) nucleic acid amplification technique and nucleic acid hybridization for the detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae.

The AMPLICOR CT/NG Test is based on the same four major processes described above for the COBAS® AMPLICOR CT/NG Test.


** The COBAS® AMPLICOR (CT/NG) Test is not available in the US for testing female urine specimens for N. gonorrhoeae.
*** The COBAS® AMPLICOR (CT/NG) Test is not available in the US for testing urethral swab specimens from asymptomatic males for N. gonorrhoeae.

 
© 2009, Roche Diagnostics See our Legal Statement - Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.

 
Visitor Insights Survey
Welcome to Roche Molecular Diagnostics

Whether you are a first-time visitor or a frequent visitor, we would appreciate your opinion to help improve our Web site.

Would you be willing to answer a brief questionnaire? It will take less than 5 minutes.

YesNo, thanks

This questionnaire is voluntary and your use of this Web site is not conditional upon your participation.

The questionnaire does not include any health-related questions, it strictly focuses on Web-related topics. In accordance to Roche's privacy policy, your responses will be treated with the strictest of confidence and not passed on to any third parties for their marketing purposes.